There is growing evidence that RNF213 and its mutants are linked to vasculopathy with a range of clinical presentations that include MMD as well as other intracranial and systemic vasculopathies (Hiraide et al., 2022). The gene discussed is RNF213; the disease is multiminicore myopathy.